Two-Phase MDCT Protocol for the Screening of Small Hepatocellular Carcinoma

Screening programmes for cirrhotic patients are based on ultrasound (US) examinations at 6-month intervals, but a US sensitivity of 47% has recently been reported. The aim of this study was to evaluate a two-phase MDCT protocol in terms of hepatic nodule detection within a hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Paisant, Anita, Boursier, Jérôme, Dabli, Djamel, Lebigot, Jérôme, Oberti, Frédéric, Michalak, Sophie, Vilgrain, Valérie, Aubé, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330229/
https://www.ncbi.nlm.nih.gov/pubmed/35893371
http://dx.doi.org/10.3390/jcm11154282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330229/
https://www.ncbi.nlm.nih.gov/pubmed/35893371
http://dx.doi.org/10.3390/jcm11154282

Ejemplares similares